Study Stopped
Close-out of the grant - study ceased on 1/1/2010
Obesity and Weight Loss on Reproductive Function
The Effects of Morbid Obesity and Weight Loss on Reproductive Function: The Bariatric Surgery Model
1 other identifier
observational
35
1 country
1
Brief Summary
The purpose of this study is to examine how obesity and weight loss following bariatric surgery affect reproductive function. The study is particularly interested in how changes in hormones (those produced in the stomach and fat tissue) following weight loss affect reproductive function. Specifically, we, the researchers at Penn State University, propose to characterize reproductive abnormalities in morbidly obese men and women. We hypothesize that morbid obesity leads to reproductive abnormalities in men and women. We plan to examine the short-term effects of alteration in GI hormones after bariatric surgery on reproductive function. We hypothesize that bariatric surgery radically alters GI hormone expression, resulting in immediate changes to the hypothalamic-pituitary-gonadal axis in men and women. Lastly, we, the researchers, plan to examine the long-term effects of weight loss and changes in adipokines on reproductive function. We hypothesize that the changes in adipokine levels resulting from fat mass reduction lead to substantial long-term improvements in reproductive function and fertility. We also hypothesize that there are sexual dimorphisms in adipokine levels following weight loss, with women experiencing larger changes than men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2005
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
September 1, 2005
CompletedFirst Posted
Study publicly available on registry
September 2, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedNovember 16, 2015
November 1, 2015
4 years
September 1, 2005
November 13, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Integrated levels of urinary progestin (Pregnanediol-3-Glururonide or Pd3G) at 12 months
12 months
Eligibility Criteria
Participants eligible for bariatric surgery; BMI \>40 or between 35 and 39.9 with a weight related health problem; Failed medical weight loss; Ages 18-40; Not using hormonal contraceptives; Females have not undergone and bilateral oophrectomy or hysterectomy; Males have not had a vasectomy
You may qualify if:
- Body mass index (BMI) of greater than 40 or a BMI between 35.5-39.9 and has a weight related health problem, such as diabetes or high blood pressure.
- Failed medical weight loss
- Ages of 18-40
- Not using hormonal contraception or sex steroids
- Subject is premenopausal and has not undergone a bilateral oophorectomy or hysterectomy
- Subject's obesity has no medical explanation (hypothyroidism, Cushing's Syndrome, genetic)
You may not qualify if:
- Not willing to make a lifelong commitment to the diet and exercise guidelines following bariatric surgery
- Subject is pregnant or lactating
- Not willing to use barrier contraceptives or intrauterine device (IUD) to prevent pregnancy for one year following bariatric surgery
- Post-menopausal, either surgical or natural
- Subject has had a vasectomy
- Subject is a smoker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Milton S. Hershey Medical Centerlead
- Tobacco Settlement Grantcollaborator
Study Sites (1)
The Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
Biospecimen
whole blood \& urine
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Legro, M.D.
Penn State University/Milton S. Hershey Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Obstetrics and Gynecology and Public Health Sciences
Study Record Dates
First Submitted
September 1, 2005
First Posted
September 2, 2005
Study Start
June 1, 2005
Primary Completion
June 1, 2009
Study Completion
December 1, 2009
Last Updated
November 16, 2015
Record last verified: 2015-11